Facile Preparation of Danazol Nanoparticles by High-Gravity Anti-solvent Precipitation (HGAP) Method

Hong Zhao; Jiexin WANG; Haixia Zhang; Zhigang SHEN; Jimmy Yun; Jianfeng CHEN

doi:10.1016/s1004-9541(08)60210-4

Facile Preparation of Danazol Nanoparticles by High-Gravity Anti-solvent Precipitation (HGAP) Method

Hong Zhao, Jiexin WANG, Haixia Zhang, Zhigang SHEN, Jimmy Yun, Jianfeng CHEN

In: Chinese Journal of Chemical Engineering · 2009 · vol. 17(2) , pp. 318–323 · doi:10.1016/s1004-9541(08)60210-4 · W1480293018

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by qwen3.7-flash, 2026-08-15 ⓘ

This paper describes the facile preparation of danazol nanoparticles using a high-gravity anti-solvent precipitation method, though no specific findings or disease links are provided in the available text.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs 1995

References (30)

Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs via openalex
doi:10.1016/s0032-5910(99)00062-5 via openalex
doi:10.1016/s0939-6411(00)00091-6 via openalex
doi:10.1016/s0896-8446(97)00011-9 via openalex
doi:10.1016/s1672-2515(07)60110-9 via openalex
doi:10.1002/1521-3773(20011203)40:23<4330::aid-anie4330>3.0.co;2-w via openalex
doi:10.1021/ie030630k via openalex
doi:10.1021/ie0201213 via openalex
W2112906517 via openalex
W2434426922 via openalex
W2469325458 via openalex
W4285719527 via openalex
doi:10.1016/s0378-5173(96)04704-7 via openalex
doi:10.1006/jcis.2000.7012 via openalex
doi:10.1016/j.ijpharm.2003.09.044 via openalex
doi:10.1021/ed032p294.2 via openalex
doi:10.1016/j.partic.2008.04.001 via openalex
doi:10.1021/cr030027b via openalex
doi:10.1023/a:1021410028371 via openalex
doi:10.1021/ie990549a via openalex
doi:10.1016/j.ces.2004.11.033 via openalex
doi:10.1021/ie0503646 via openalex
doi:10.1016/j.cep.2005.12.006 via openalex
doi:10.1023/a:1020390422785 via openalex
doi:10.1016/s0255-2701(99)00025-2 via openalex
doi:10.1016/j.cep.2007.05.013 via openalex
doi:10.1002/jps.10352 via openalex
doi:10.1016/0378-5173(95)00148-c via openalex
doi:10.1016/s0378-5173(01)00803-1 via openalex
doi:10.1016/0009-2509(91)80035-w via openalex

Source provenance

openalex: last seen: 2026-05-10T11:16:29.908403+00:00

License: CC0 · commercial use OK

[1] Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs 1995